Acadia Healthcare Co Analyst Ratings
Pediatrix Medical Group Analyst Ratings
AMN Healthcare Services Analyst Ratings
PACS Group Analyst Ratings
Pennant Gr Analyst Ratings
Fresenius Medical Care Analyst Ratings
DaVita Analyst Ratings
Acadia Healthcare Co Analyst Ratings
RBC Raises Price Target on PACS Group to $32 From $30, Keeps Outperform Rating
Truist Financial Keeps Their Hold Rating on DaVita (DVA)
Truist Financial Sticks to Their Hold Rating for Pennant Group (PNTG)
Truist Financial Sticks to Its Hold Rating for Fresenius Medical Care (FMS)
Truist Financial Sticks to Their Hold Rating for Aveanna Healthcare Holdings (AVAH)
Analysts Have Conflicting Sentiments on These NA Companies: Metagenomi, Inc. (MGX), Smith Douglas Homes Corp. Class A (SDHC) and PACS Group Inc (PACS)
Truist Securities Raises Price Target on DaVita to $150 From $135, Keeps Hold Rating
Truist Securities Adjusts Price Target on Fresenius Medical Care to $24 From $21, Maintains Hold Rating
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Acadia Healthcare (ACHC) and Taysha Gene Therapies (TSHA)
AMN Healthcare Services: Hold Rating With Positive Long-Term Outlook Amid Near-Term Pressures
Buy Rating Affirmed for Encompass Health on Strong Growth and Strategic Management
Buy Rating Justified for Option Care Health Amid Revenue Growth and Strategic Adaptability